So percentage-wise, we have a lot of international interest we've always had out there. We're registered in probably north of 30 countries around the world. Again, the problem has been recently we've noticed a decrease in international sales. I think it's because, number one, is many of the people in international markets that use our product have been shut down and have been sequestered to their homes. Businesses like the United States have not been functional in that way. Number two, we feel that the price, entry price, has been a problem internationally, and that's another reason, another great reason for the production of our Steripaks. which we feel internationally this will be a forerunner of driving sales, except for those professional biotech, biosafety, pharmaceutical companies that are going to always use our main product, our surface environment unit and built-in systems. That's number two. We'll also soon be able to start traveling. A big part of the loss of international revenue is the inability to travel internationally. And now that things are opening up in some parts of the world, not in all of them, unfortunately, but in some parts of the world, we're beginning to have interest of going out and doing demos and doing bids on our complete engineered system. So I think you can count on seeing greater international revenue going forward as you know, this country is opening and as the rest of the world starts to open and with the release of our new product line.

May 17, 2021 / CEO / receipt, needs a key / Dr. Holden Shane, CEO | earnings call 2021-05-17 | transcript e158ee18-f012-44e3-96b9-bc050d5a5a4b | chars 20375-21873 | segment 20